Breaking Business News | Breaking business news AM | Breaking Business News PM

: Regeneron’s antibody drug is the first specifically-designed COVID-19 treatment added to leading U.K. trial

15 Sep 2020

U.S. biotech company Regeneron’s experimental drug is being added to one of the world’s leading coronavirus treatment trials.

Read the full article here.
This content was originally published by - Top Stories. Original publishers retain all rights. It appears here for a limited time before automated archiving. By - Top Stories

Covid-19 – Johns Hopkins University

Download brochure

Introduction brochure

What we do, case studies and profiles of some of our amazing team.